Using GIS to Identify Priority Sites for Colorectal Cancer Screening Programs in Texas Health Centers

Overview

Journal Prev Chronic Dis

Specialty Public Health

Date 2023 Mar 2

PMID 36862605

Authors

F Benjamin Zhan

Yanyan Liu

Mei Yang

Nicole Kluz

Todd A Olmstead

Jenny Spencer

Navkiran K Shokar

Roxana L Cruz

Michael P Pignone

Affiliations

Soon will be listed here.

Citing Articles

Increasing COVID-19 Testing and Vaccination Uptake in the Take Care Texas Community-Based Randomized Trial: Adaptive Geospatial Analysis.

Zhang K, Hunyadi J, de Oliveira Otto M, Lee M, Zhang Z, Ramphul R JMIR Form Res. 2025; 9:e62802.

PMID: 39935005 PMC: 11835599. DOI: 10.2196/62802.

Cost-Effectiveness of Noninvasive Colorectal Cancer Screening in Community Clinics.

Nascimento de Lima P, Matrajt L, Coronado G, Escaron A, Rutter C JAMA Netw Open. 2025; 8(1):e2454938.

PMID: 39820690 PMC: 11739995. DOI: 10.1001/jamanetworkopen.2024.54938.

Using Geospatial Analysis to Identify Priority Communities for Cervical Cancer Prevention in Texas.

Sokale I, Thrift A, Montealegre J, Chido-Amajuoyi O, Adekanmbi V, Oluyomi A AJPM Focus. 2024; 3(4):100247.

PMID: 39034933 PMC: 11260362. DOI: 10.1016/j.focus.2024.100247.

Individual and geospatial factors associated with receipt of colorectal cancer screening: a state-wide mixed-level analysis.

Bayly J, Schonberg M, Castro M, Mukamal K Fam Med Community Health. 2024; 12(Suppl 2).

PMID: 39029926 PMC: 11664332. DOI: 10.1136/fmch-2024-002983.

References

Joseph D, King J, Dowling N, Thomas C, Richardson L . Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018. MMWR Morb Mortal Wkly Rep. 2020; 69(10):253-259. PMC: 7075255. DOI: 10.15585/mmwr.mm6910a1. View

Jager M, Demb J, Asghar A, Selby K, Mello E, Heskett K . Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis. Dig Dis Sci. 2019; 64(9):2489-2496. PMC: 6706307. DOI: 10.1007/s10620-019-05587-6. View

Gupta S, Coronado G, Argenbright K, Brenner A, Castaneda S, Dominitz J . Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin. 2020; 70(4):283-298. PMC: 7523556. DOI: 10.3322/caac.21615. View

Cusumano V, May F . Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs. J Gen Intern Med. 2020; 35(6):1870-1874. PMC: 7280423. DOI: 10.1007/s11606-020-05728-y. View

Davis M, Freeman M, Shannon J, Coronado G, Stange K, Guise J . A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?. BMC Cancer. 2018; 18(1):40. PMC: 5756384. DOI: 10.1186/s12885-017-3813-4. View

Ramai D, Etienne D, Ayide G, Fields P, Reddy M . Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population. J Clin Gastroenterol. 2018; 53(10):744-749. DOI: 10.1097/MCG.0000000000001132. View

Ni K, OConnell K, Anand S, Yakoubovitch S, Kwon S, de Latour R . Low Colorectal Cancer Screening Uptake and Persistent Disparities in an Underserved Urban Population. Cancer Prev Res (Phila). 2020; 13(4):395-402. PMC: 7127936. DOI: 10.1158/1940-6207.CAPR-19-0440. View

Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 315(23):2564-2575. DOI: 10.1001/jama.2016.5989. View

White A, Thompson T, White M, Sabatino S, de Moor J, Doria-Rose P . Cancer Screening Test Use - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017; 66(8):201-206. PMC: 5657895. DOI: 10.15585/mmwr.mm6608a1. View

10.

Zhan F, Morshed N, Kluz N, Candelaria B, Baykal-Caglar E, Khurshid A . Spatial Insights for Understanding Colorectal Cancer Screening in Disproportionately Affected Populations, Central Texas, 2019. Prev Chronic Dis. 2021; 18:E20. PMC: 7938962. DOI: 10.5888/pcd18.200362. View